Latest
Paralign Health Raises $3M Seed to Expand EMS-Led Preventive Care InfrastructureParalign Health Raises $3M Seed to Expand EMS-Led Preventive Care Infrastructure|Blulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic PowerBlulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic Power|Secretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective AgainSecretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective Again|Trajectory Raises $15M Seed to Build Continual Learning AI InfrastructureTrajectory Raises $15M Seed to Build Continual Learning AI Infrastructure|Rightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic BattlegroundRightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic Battleground|Amusement Connect Raises Periscope Equity Investment for Cashless Arcade SoftwareAmusement Connect Raises Periscope Equity Investment for Cashless Arcade Software|Sychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive TrackingSychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive Tracking|Why Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup MarketWhy Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup Market|Salesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure TestSalesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure Test|AWS for Startups AI Visionaries Forum Signals the Next Enterprise AI BattlegroundAWS for Startups AI Visionaries Forum Signals the Next Enterprise AI Battleground|Paralign Health Raises $3M Seed to Expand EMS-Led Preventive Care InfrastructureParalign Health Raises $3M Seed to Expand EMS-Led Preventive Care Infrastructure|Blulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic PowerBlulabs Raises $7M as Supply Chain Infrastructure Becomes Strategic Power|Secretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective AgainSecretome Therapeutics Raises $30M Series A as Cell Therapy Capital Gets Selective Again|Trajectory Raises $15M Seed to Build Continual Learning AI InfrastructureTrajectory Raises $15M Seed to Build Continual Learning AI Infrastructure|Rightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic BattlegroundRightsline Lands $500M From Hg as IP Infrastructure Becomes a Strategic Battleground|Amusement Connect Raises Periscope Equity Investment for Cashless Arcade SoftwareAmusement Connect Raises Periscope Equity Investment for Cashless Arcade Software|Sychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive TrackingSychedelic Raises $3.5M Seed to Push Consumer Neurotech Beyond Passive Tracking|Why Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup MarketWhy Whitnie Narcisse’s Networking Masterclass Matters in a Slower Startup Market|Salesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure TestSalesforce Connections 2026 Turns Chicago Into an AI Marketing Pressure Test|AWS for Startups AI Visionaries Forum Signals the Next Enterprise AI BattlegroundAWS for Startups AI Visionaries Forum Signals the Next Enterprise AI Battleground
Back to articles

LanzaJet Secures $47M in Initial Funding of $135M Round, Valued at $650M Pre-Money

There are moments in aviation when the engines are quiet, but the signal is loud. This is one of them. LanzaJet just pulled in $47M in the first close of a $135M equity round, landing at a $650M...

There are moments in aviation when the engines are quiet, but the signal is loud. This is one of them. LanzaJet just pulled in $47M in the first close of a $135M equity round, landing at a $650M pre-money valuation. Not theory. Not lab coats and pitch decks. Real capital behind real fuel. The round was co-led by International Airlines Group and Shell, with Groupe ADP, LanzaTech, and Mitsui & Co. doubling down as returning investors. When airlines, energy majors, airport operators, and global industrial players all lean in at the same table, that is not a coincidence. That is choreography.

Congratulations to Jimmy Samartzis, CEO and Board Director of LanzaJet, and Dr. Jennifer Holmgren, Chair of the LanzaJet Board and CEO of LanzaTech. This is what disciplined scale looks like. Build the tech. Prove it commercially. Then invite the world’s largest fuel buyers and suppliers to invest in the future they need.

LanzaJet is not selling hope. They are producing sustainable aviation fuel and renewable diesel through proprietary Alcohol-to-Jet technology that converts low-carbon ethanol into drop-in fuel. Drop-in is the key phrase. No new engines. No exotic infrastructure. The molecule shows up ready to work. At Freedom Pines Fuels in Soperton, Georgia, the world’s first commercial ethanol-to-jet facility is already expected to produce roughly 9M gallons of SAF and 1M gallons of renewable diesel annually. That is not a pilot. That is proof.

This capital fuels 2 things at once: operations at Freedom Pines and global deployment of the ATJ platform, including Project Speedbird in Teesside in the United Kingdom. The play is elegant. De-risk with a reference plant. Attract strategic capital from those who will buy, blend, and move the fuel. Then replicate with precision.

There is a business lesson humming under all of this. LanzaJet did not chase applause. They aligned incentives. When your investors are also your future customers and infrastructure partners, growth stops being a gamble and starts becoming a supply chain.

Sustainable aviation fuel is no longer a panel discussion topic. It is a balance sheet line item. And LanzaJet is positioning itself as the jet bridge between ethanol and altitude, between policy ambition and commercial reality.

The runway is long. The demand is global. The capital is strategic. And the companies that understand molecules, margins, and momentum at the same time are the ones that will decide how aviation decarbonizes from here.